Back to Search
Start Over
Correction: Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer
- Source :
- BMC Medicine, Vol 22, Iss 1, Pp 1-1 (2024)
- Publication Year :
- 2024
- Publisher :
- BMC, 2024.
- Subjects :
- Medicine
Subjects
Details
- Language :
- English
- ISSN :
- 17417015
- Volume :
- 22
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- BMC Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.b4216edbde114af99a0b2210e96fa4da
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s12916-024-03644-0